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Synthetic  polymers,  nanoparticles,  and carbon-based materials  have  great  potential  in
altering  biological  functions,  drug  delivery,  gene  transfection,  in  vitro and  in  vivo
imaging.  Nature  and  humans  use  different  design  strategies  to  create  nanomaterials:
biological objects have emerged from billions of years of evolution and from adaptation
to  their  environment  resulting  in  high  levels  of  structural  complexity.  In  contrast,
synthetic nanomaterials result from minimalistic but controlled design options limited by
our current understanding of the biological world. This conceptual mismatch makes it
challenging to create synthetic nanomaterials possessing desired functions in biological
media. An essential transport barrier is the cell protecting plasma membrane and hence
the  understanding  of  its  interaction  with  nanomaterials  is  a  fundamental  task  in
biotechnology. We present open questions in the field of interaction of nanomaterials with
biological membranes, including: how physical mechanisms and molecular forces acting
at the nanoscale restrict or inspire design options; which levels of complexity to include
next  in  computational  and  experimental  models  to  describe  nanomaterials  crossing
barriers via passive or active processes; and how the biological media and protein corona
interfere with the functionality of nanomaterials. In this perspective article, we address
these questions with the aim to offer guidelines for the development of next-generation
nanomaterials to function in biological media.
3I. INTRODUCTION
Functional nanomaterials are used in many products of our daily life, from 
sunscreens to toothpastes1, but bring uncontrolled risks such as nanotoxicity, and 
environmental pollution2,3. The proper design of “smart” or “intelligent” nanomaterials 
that perform a desired function in living organisms is an appealing but challenging task: 
the complexity of living organisms results from their adaptation to the environment 
during billions of years of evolution, whereas fabrication of synthetic nanomaterials is 
usually based on the optimization of a relatively small number of parameters. By offering
precise control of design parameters, robustness and simplicity of construction, synthetic 
nanomaterials can promise new functions that do not yet exist in the biological world. 
However, the changes that they induce in complex biological media and their lack of 
adaptability may compromise the design goals due to degradation or limited 
biocompatibility. The design of biologically active nanomaterials therefore requires a 
clear definition of the design goals, the conception and implementation of the material as 
well as its testing. While essential parameters – size, shape, elasticity, composition and 
surface properties – of nanomaterials have been identified,4,5 and the chemical properties 
can be precisely controlled, the major challenges in nanomaterial design arise in 
monitoring, understanding, and controlling their interaction with biological media,6 
ranging from specific biological barriers to the immune system.
Using the prototypical example of transport of nano-objects into eukaryotic cells, 
we map out the difficulties of nanomaterial design, and elaborate our opinion on how 
4design obstacles are linked to fundamental questions in understanding transport into 
living cells. We also highlight starting points for extending experimental and theoretical 
models for the prediction of a nanomaterials’ functionality in biological environments: 
what are the next degrees of increased complexity that are most important to consider? In
particular, in section 2 we describe where we see the major obstacles for an optimal 
design flow that integrates all necessary design steps. In section 3 we focus on challenges
in understanding and exploiting already known mechanisms of nanomaterial transport 
across plasma membranes, and in section 4 we give examples on how the presence of 
biological media challenges theoretical and experimental approaches but also inspires 
new conceptions.
II. MISSING LINKS TO BIOLOGICAL CONTEXT
When coming from a physical and chemical background one often focuses on 
microscopic mechanisms of nanomaterial interaction with model environments such as 
single component lipid membranes, although the biological context is essential for 
formulating critical design goals and testing their functionality. 
Modern chemistry allows us to synthetize a large variety nanomaterials with a 
broad range of architectures (e.g. quantum dots, polymers, nanostars, nanorods, 
nanodisks, nanocages), chemical composition (organic/inorganic, liquid/solid), and 
surface properties (e.g. decoration with ligands and charges)7. A good illustration on 
recent progress in advanced synthesis is the possibility to dynamically control the number
of ligands on 23-gold-atom nanoparticle within so-called molecular surgery.8 With fairly 
high precision, one can control the chemical composition of nanomaterials, the length and
order of synthetic peptide sequences, and the architecture, chemistry and length of 
5synthetic polymers. Yet it is often not clear how chemical properties translate into 
physical control parameters when embedded in highly complex biological media. Beside 
the extensively discussed protein corona around nanoparticles,9 more emphasize should 
be put on the question of how the protein-crowded environment, co-solvent properties, 
ionic strength and ion complexation, or pH modify the conformation and function of soft 
objects such as polymers or nano-gels. In turn, the impact of nanomaterials on the 
biological environment can be subtle. For example, one has observed that the band 
structure of metal oxide-based nanomaterials is an important factor for their toxicity. 
Depending on the band gap, these materials may interfere with the level of oxidative 
stress and can thereby be toxic [[Use of Metal Oxide Nanoparticle Band Gap To Develop 
a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation]].
While theoretical and simulation approaches often investigate populations of 
identical nano-objects with idealised properties such as perfectly smooth spherical 
nanoparticles or monodisperse polymers, real nano-objects are not so pristine and, for 
instance, exhibit variations in surface roughness, polydispersity, and heterogeneity within
a sample. Since small differences between nano-objects can be critical for their 
interaction with biological media, different fates are expected already from small 
variations in their properties, including decomposition into sub-populations due to the 
complex nature of the interactions. 
Due to the Abbe diffraction limit, it is in aqueous solutions challenging to obtain 
insights at the molecular scale. However, optical imaging can reveal significant insights 
into the impact of non-objects on membrane properties, such as membrane morphology,10
dynamics11 and permeability.12 Furthermore structural insights can be gained from 
6spectroscopic methods.13 Towards imaging of individual nanoparticles, alternative 
approaches, such as Stimulated Emission Depletion Microscopy (STED)14,15 and electron
microscopy16 are applied. Microfluidic and electrochemistry methods can be applied 
together to monitor individual translocation events of single and clustered nano particles 
across model lipid membranes.17
III. CHALLENGES FOR TRANSPORT ACROSS LIPID-
BILAYER MEMBRANES
Whereas there is evidence for insertion and translocation of nano-objects such as 
cell-penetrating peptides, polymers, or coated nanoparticles across biological and lipid 
membranes from experiment and simulation, the thermodynamic driving forces and the 
molecular mechanisms for translocation remain hotly debated.18–21 In analogy to other 
topology-altering (Fig. 1) membrane processes, such as fusion, fission and pore 
formation,22 the passage across a membrane can be roughly subdivided into an initial 
recognition or docking stage and the subsequent penetration, as well as the separation of 
the object from the membrane. Generally, one may distinguish between active, assisted 
and passive transport across a membrane. Furthermore, one shall distinguish 
translocation mechanisms by direct penetration of the membrane's core or pore 
formation from endocytic pathways involving the wrapping of nano-objects into an 
invagination. For the design of a nano-object it is crucial to consider that the translocation
and endocytosis lead to fundamentally different topological situations.
Active Transport
7Active transport refers to mechanisms that are enabled by an expenditure of 
chemical energy. Endocytotic pathways are widely associated with active processes,23 
since in biological environments dynamin catalyses the separation step of an 
invagination.24,25 Grafting of lipoproteins and other ligands onto nano-objects will make it
possible to exploit active endocytic and phagocytic machineries of cells by binding to 
specific membrane receptors in the docking step.
Fig. 1 Challenges and open questions in transport across a cell membrane.
Ion and glucose transporters are other common examples of protein machineries 
that facilitate active translocation across a membrane. Protein machineries that 
specifically transport also synthetic nano-objects across a bilayer are missing. Developing
such a machinery will be particularly worthwhile because it has the potential to impart 
high selectivity onto translocation. Existing concepts on passive polymer translocation 
8through nano-pores26  as well as voltage driven DNA translocation through biological 
pores27 can be a starting points to develop translocation machineries for nano-objects 
driven by local chemical energy (ATP). It is this crucial to study more deeply the 
mechanisms of the existing trans-membrane transporters and active lipid flip-flop 
catalysing proteins. An interesting avenue of research could be aimed at finding minimal 
synthetic analogues or modifications of those proteins, so that they bind to nano-objects 
and subsequently catalyse their translocation. Accurately predicting the catalytic role of 
active proteins interacting with nano-structures is an open field for molecular simulation 
techniques. Intervening in active and regulatory transport systems can, however, easily 
show the fate of over-ambition: A nanomaterial that tempers into active machineries such 
as glucose- or ion transporters [[10.1016/j.tox.2009.08.005, 
10.1098/rsif.2010.0158.focus, 10.1186/s12951-017-0327-9]], or active 
lipid exchangers between leaflets, may cause unpredictable regulatory failure and toxic 
effects.
Assisted Transport
Assisted translocation exploits global non-equilibrium processes or local response
of the membrane that facilitate translocation processes, but that are not directly related to 
the translocation mechanism. A prototypical illustration of global non-equilibrium aspects
is a translocation process that exploits the actively maintained lipid or protein asymmetry 
between the inner and outer monolayers. An interesting challenge is the possible transport
of nano-objects driven by chemical potential differences – for instance, by developing 
analogues of secondary transporters. Another example of assisted translocation is the 
9enhanced permeability at boundaries between lateral lipid 
domains28[[10.1039/C7NR08351C]] and the potential role of near-critical composition 
fluctuations or raft-like domains,29 as well as interfaces between lipids and membrane-
inserted nano-objects with critical hydrophobicity.30 The adsorption of nano-objects at the
membrane may locally alter the composition of the membrane in contact with the nano-
object, and, in turn, facilitate translocation of the object.31 
Endocytic pathways are assisted by families of curvature-inducing proteins that 
attach to the membrane: clathrin and BAR proteins. Anisotropic and Janus nanoparticles 
can mimic curvature-inducing proteins32,33, and promote the formation of invaginations34. 
In-vitro experiments indicate that so-called N-BAR proteins, by having a transmembrane 
domain, promote endocytosis in the absence of dynamin, while pure BAR-domains seem 
to restrict fission but support tubular shapes.35 On one hand it is often discussed that 
specific assisting mechanisms are required for the final pinch-off to occur; on the other 
hand computer simulations indicate that spontaneous endocytosis of wrapped 
nanoparticles also occurs in cases where N-BAR or equivalent molecules are not 
present.36–39 A key question here is how the barriers for altering membrane topology and 
concomitant time scales depend on the object enclosed. To this end, the prediction of the 
pinch-off dynamics and time scales can be seen as benchmark case for molecular 
simulation models. It is particularly challenging to map time scales and free energy 
barriers between atomistic and coarse-grained models – motivating the development of 
new simulation techniques bridging the gap. Beside computer simulation, it will be 
worthwhile to test existing theoretical models for the pinch-off40,41 and the role of 
“universal membrane remodellers”42 via  focused experiments with model membranes. 
1An interesting question to address is the relation between nano-object size, and the 
spontaneous curvature induced by assisting proteins or synthetic analogues: can we 
predict matching sizes and shapes for selective transport? 
An important aspect of nano-object transport attracting more attention is the role 
of cell membrane tension, which natively is in the order of 0.01mN/m.43 In many cases 
the underlying actin cortex is also relevant by inducing a cortical tension in the order of 
0.01 – 1 mN/m (see for example44). Experimental evidence shows that endocytosis 
efficiency typically decreases with increasing membrane tension, but for some cell types 
the response can be inverse.45 Theoretically, it is expected that tension-induced restraining
forces for particle wrapping appear for particle sizes larger than a characteristic length 
scale defined by bending rigidity and tension.46 For larger particles, the degree of 
wrapping is controlled by the competition between tension and adhesion.47 The release of 
membrane reservoirs43 and membrane remodelling48 upon increasing tension or areas 
consumed by wrapping, complicate the situation. Before disentangling all contributions 
in biological environments, however, it will be interesting to investigate wrapping and 
endocytosis as a function of tension in model experiments with reduced complexity. 
Tension of the membrane can play a crucial role also for translocation pathways across a 
membrane. The probability of transient pores induced, for instance, by cell-penetrating 
peptides is expected to be sensitive to the ratio between cell membrane tension and line 
tension of the pore.49
Passive transport
Passive translocation refers to diffusion of small (<10 nm) nano-objects across 
the membrane, which is chiefly dictated by the properties of the nano-objects and their 
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interactions with the membrane. By passive we mean processes that do not require any 
external forces or gradients of other components between both sides of the membrane. 
They are rather robust, fast and present a universal platform for developing translocation 
approaches. In particular, stimuli-responsive coatings with multicomponent brushes 
provide ample opportunities to tailor the passive translocation processes by 
environmental characteristics such as pH, salt concentration or temperature.50 The ratio 
between nano-object size and the membrane thickness as well as its geometric shape are 
critical parameters.51 Additionally, the mechanical or chemical responsiveness of the 
nano-object,52 i.e., the deformability, and adaptability of the chemical surface 
composition and charge determine insertion and translocation. Flexible polymers in 
contact with a membrane may undergo conformational changes such as a coil-globule 
transitions.53,54 It is suggested that some cell penetrating peptides switch to helical 
amphipathic structure in the presence of the membrane.55,56 In addition, making synthetic 
analogues of these self-assembled peptides is a challenge. Surface properties of a nano-
object can be controlled, e.g., by grafting polymers onto the surface of the nano-object.57 
Beside passive translocation across the membrane also “passive endocytosis” was 
hypothesised58 and debated over several decades.59 The docking step and wrapping of 
nanoparticles has been described theoretically,46,60 and explored numerically as a function 
of shape and adhesion strength of the particle at the membrane.51,61 While the formation 
of an invagination can be driven by adhesion at the membrane as observed in model 
experiments,11 it remains an interesting question to what extent assisted or active 
processes are essential for the final pinch-off.
IV. CHALLENGES IN BIOLOGICALLY COMPLEX MEDIA
1Experimental and theoretical studies on the interactions between synthetic nanomaterials 
and membranes in biomimetic or in in vitro cellular systems often assume nano-objects of
idealized shape, size, and surface in a simple fluid environment. Typical solvent 
environments considered are salt buffers such as phosphate buffered saline or water with 
a given concentration of monovalent ions respectively, while biological membranes are 
embedded in molecularly crowded aqueous environment, such as the cytoplasm and 
extracellular fluids.
Properties of the surrounding media
Ionic components, proteins or RNA do not only determine simple physical 
properties such as pH and screening of electrostatic interactions. Very recently it has been
discovered that several types of proteins together with RNA give rise to spatially 
controlled intracellular phase separation into droplets, called RNA bodies or granules.62 If
foreign substances such as macromolecules, micelles, or nanoparticles are inserted into 
living systems, it is very likely that their properties and interactions with the cell 
membranes are different from those in simple aqueous solutions. For instance bare 
nanoparticles can adsorb proteins and thus change their surface properties,63 but polymers
also can change their properties by adsorbing and binding components of the biological 
fluid. For instance,64 the puzzling phenomenon of passive translocation of positively 
charged arginine-rich peptides, and even of oligo-arginines, was explained by the binding
of (counter-)anions from the buffer. Few theoretical and simulation studies have taken 
into account complex formation between nano-objects and other components typical for 
biological solutions including binding of counter-ions. The compensation of charge in 
1polymers such as polypeptides can switch the monomer solubility from hydrophilic to 
hydrophobic since in many cases the uncharged backbone is hydrophobic. If nano-objects
are close to the membrane this binding process can be further influenced by the 
interaction with the membrane in particular by the charge and counterions located near 
the lipid head-groups. It must be noted that arginine itself is positively charged and 
strongly hydrophilic which should prevent any passive pathway of these polymers 
through lipid bilayer membranes. Arginine-rich peptides such as TAT or homeoprotein 
transcription factors appear in nature and thus are evolutionarily optimized in the 
presence of biological fluids. Recently it was demonstrated that also cube-octameric 
silsesquioxanes65 with similar positively charged ligands efficiently translocate through 
cell membranes. Experimental evidence thus opens new possibilities for developing bio-
inspired cell-penetrating nano-objects but also presents a challenge for theory and 
experiments using model membranes in artificial environments. A key question is how 
many and which components of extracellular fluids (if considering the insertion process 
into the cell) are essential in order to mimic a typical extracellular environment in a 
representative way? Is there a standard for such a biological medium that is elementary 
enough to retain the advantages of minimal model systems? Is there a better standard for 
a biological medium than the typically used phosphate-buffered saline suspensions (pH 
7.4 and physiological salt levels) to study nano-object membrane interactions? 
Nanomaterials represent length scales where molecular crowding of cellular as well as 
intracellular environments substantially influence diffusion dynamics, excluded volume 
effects, and inter-molecular association [[Ellis 2001]]. The new standard medium 
1therefore potentially contains crowding agents such as PEG or polysaccharides in order to
simulate those effects [[10.1110/ps.03288104.]].
Another level of complexity arises when taking into account dynamically 
changing environments. As an example, during endocytic uptake of nanoparticles, the 
endosomal compartment is acidified, which can lead to protonation of functional groups 
on a particle’s surface changing its net charge. In the endosome, this change in the pH of 
the environment is coupled with a change in the lipid composition of the interacting 
endosomal membrane, which can lead to significant changes in the nanomaterial’s ability 
to disrupt or cross the membrane.78 
Recent attention is attracted by the dynamic feedback that membranes may induce
in biological media via the recruitment of curvature-sensing proteins: One has found that 
membrane curvature and cortical proteins both can take part in coupled oscillations of 
shape and concentration [[10.1073/pnas.1221538110 ,  10.1038/s41467-017-02469-1]], 
which presumably contribute to cell signaling processes. How would a nanomaterial 
interfere with those dynamics?
Protein Corona
In physiological environments, a large number of proteins and other biomolecules
are present. These molecules can rapidly bind in a temporally complex way to nano-
objects, and form fluctuating coronas around nano-objects that may have a strong 
influence on their interactions with a biological environment.67–70 In analogy with the 
Vroman effect,71,72 the composition of coronas may vary dramatically over time.73
Nanoparticles that are immersed in human blood serum have coronas that consist 
of proteins such as albumin, immunoglobulins, fibrinogen, apolipoproteins as well as 
1proteins from the complement system.9,74,75  There is a large class of proteins called 
opsonins that label foreign objects to be detected by immune system, and trigger the 
uptake by phagocytes and macrophages. In contrast, another class of proteins, 
dysopsonins, including albumins and apolipoproteins are known to inhibit phagocytic 
uptake.67,76 The composition of both groups adsorbed at nanocarriers in blood serum 
controls their elimination by resident macrophages.77,78  Recent experiments, for instance, 
seem to explain the so-called stealth effect of polyethylene glycol (PEG) coatings against 
phagocytosis by the selective adsorption of lipoproteins and apolipoproteins onto the 
PEG-coated nanocarriers.79 However the hypothesis that PEGylation of particles 
increases the binding of dysopsonins that mask the particles was already put forward 
more than 15 years ago.80 Since corona formation seems almost unavoidable, the central 
challenge is to control its composition and structure as a function of time. 
Real Biomembranes
Lipid bilayers can be convenient model systems for nanoparticle-membrane 
interactions allowing detailed physical insights thanks to their relative structural 
simplicity and well characterised properties. However real biological membranes are far 
more complex in structure, containing a large amount of both integral and peripheral 
proteins81,82 plus a high degree of glycosylation, which provides a complex coating with 
polymeric sugars. Further complexity is provided by the cell membrane’s transmembrane 
asymmetry, lateral heterogeneities and underlying cytoskeleton, a dynamic network of 
semi-flexible to rigid polymers. Future theoretical and experimental model systems 
should start to take this increased membrane complexity into account in order to 
1understand the true extent to which a lipid bilayer can model nanoparticle interactions at 
a real biomembrane. For example, giant unilamellar vesicles can be fabricated directly 
from the plasma membranes of mammalian cells and are known as giant plasma 
membrane vesicles (GPMVs).83 They contain most of the natural components of a real 
cell membrane but without the active processes of a real cell. Therefore, these materials 
are ideal experimental systems to bridge the gap between model lipid membranes and the 
whole cell. GPMVs not only allow to test the validity of more abstract theoretical and 
experimental models, but can be a starting point to study effects of protein and lipid 
sorting as well as more specific coupling of nanomaterials with biomolecular interaction 
networks. Although structurally impaired as compared to GPMVs, planar supported 
membranes made from native cell membranes serve as additional model systems, which 
allow for a large arsenal of sophisticated surface analytical tools.84,85 
A further challenge arises in the design of nanoparticles that target a specific cell 
type. This is particularly important for nanomedicine applications, where drug loaded 
particles might be targeted to a specific sub-population of cells possessing particular 
disease pathology. In many disease states, e.g. cancers, it is known that cells upregulate 
specific cell surface receptors such that they are present in higher concentrations within 
the plasma membrane.86 Among many others, well known examples include growth 
factor receptors,87 vitamin receptors such as folate receptors88 and the transferrin 
receptor.89 In cancer, receptor overexpression is usually heterogeneous within different 
cells of a single tumour and also between different patients for a given type of cancer - 
posing a fundamental challenge when aiming for generalized descriptions of molecular 
and physical mechanisms of how nano-objects engage in receptor binding. Targeting 
1approaches have involved the attachment of high affinity ligands to the surface of a 
nanoparticle that targets these receptors. However, receptors that are overexpressed in 
disease state are also present in the membranes of healthy cells, albeit at lower 
concentrations, leaving significant chances for off-target binding to healthy cells. 
Therefore, we see a central challenge to clarify the effect of ligand density on nano-
objects on receptor-mediated uptake. Complementary, the surface density of receptors 
needs attention as playing a role for nanoparticle targeting to diseased cells. An additional
question for in vitro systems that are barely addressed in current mechanistic studies, but 
likely important to unravel the uptake process of nanoparticles, is the impact of 
hydrodynamic interactions in biological fluid flows on cell-specific adhesion.
V. CONCLUSIONS
Challenges Next levels of model complexity.
I. Missing links to biological context
The complex outcomes of modern 
chemical synthesis are often developed far 
beyond of being precisely trackable and 
having predictable interactions with 
biological media.
On the other side, abstract theoretical 
approaches easily miss essential 
complications of the biological 
counterparts they try to describe.
Statistical nature of nano-object properties 
such as polydispersity, in-sample variations
of surface shape and composition.
II. Challenges for transport across lipid bilayer membranes
How to exploit protein machineries for 
specific nano-object transport?
Include active components in molecular 
models.
Can we rationalize dynamic barriers for 
topological transitions in membranes as a 
function of molecular composition and 
curvature-inducing nano-objects?
The role of membrane tension is often not 
investigated systematically in simulation 
studies and model experiments.
III. Challenges in biologically complex media
1How many and which components of 
biological  fluids are essential in order to 
mimic a typical biological environment in a
representative way?
Is there a better standard for a biological 
medium than the typically used phosphate-
buffered saline suspensions (pH 7.4 and 
physiological salt levels) to study nano-
object membrane interactions?
- Diffusion in crowded environments 
including RNA-controlled granules
- specific counter-ion condensation
- dynamically changing solvent 
composition and pH.
- binding and interaction of membranes 
with cytoskeleton and macromolecule-
crowded media.
Can we control protein corona composition
and structure as a function of time?
Can we clarify the interplay between ligand
density and surface density of receptors for 
receptor-mediated uptake of nano-objects?
In this Perspective, we illustrate the progress and collect open questions in the 
design and function of nanomaterials interacting with lipid and biological membranes. 
The minimalistic but well controlled design approach used by scientists is conceptually 
different from biological adaptation and evolution. The mismatch between theoretical or 
experimental models with reduced complexity and the multitude of interactions concerted
within rich biological environments makes it challenging to design functional materials. 
When focusing on nanomaterial transport through membrane one notices substantial 
progress in all related fields from theoretical and experimental models, synthesis, to in 
vitro testing involving biological complexity. Both endocytic pathways as well as 
translocation by penetration through a bilayer are extensively analysed via theoretical 
models, computer simulation, and experimental studies. On the other side, chemists are 
today able to synthesize highly advanced materials involving the dynamic control of 
attached ligands (“molecular surgery”8), and to monitor the transport of complex 
materials through biological membranes.67 Even the molecular details of the immune 
response induced by polymer-based coatings and proteins have become more elucidated 
recently.79 For further progress in the design flow between theory and in vitro testing we 
emphasize the potential to close missing links between model systems and the biological 
context. From one side, theoretical and experimental model systems may include more 
systematically the next levels of complexity: active components such as enzymes, solvent
complexity and co-solvency, the nano-object´s interplay with proteins by means of 
protein corona and curvature-inducing proteins, the variation of membrane tension, 
coupling to the cytoskeleton, and the lateral structure of multi-component membranes. 
From the other side, systematic model experiments may receive more emphasize before 
direct in-vitro testing of newly synthesized materials. For example, existing theoretical 
models for adhesion- and tension-dependent wrapping are not extensively tested yet in 
model experiments. An interesting phenomenon to understand on a physical molecular 
level will be the membrane fission event during endocytosis. We illustrate the importance
of integrating the existing knowledge on membrane fusion, vesicle formation by 
membrane fission, and vesicle transport into a complete picture of the whole endocytic / 
exocytic cycle. To precisely determine topological pathway of a nano-object is crucial for
knowing which sensitive parts of a cell, e.g. DNA, are exposed to the object for causing 
potentially toxic effects. Nevertheless, itIt is important not to over-define the targeted 
functionality, and to avoid aiming for multi-functionality. Instead, it would be 
advantageous to require the nanomaterial to be as minimally specific as necessary in 
order to act as delivery vector, nanosensor, or imaging agent. Finally, we close by 
throwing two challenging question: Can we create a synthetic analogue of a complete 
endocytic cycle? Can we adapt a synthetic analogue of active ion transporters for direct 
translocation of nano-objects?
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